Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells

Virology

Volumn 326, Issue 1, 2004, Pages 57-66

  Mossadegh, Nina ^a   Gissmann, Lutz ^a   Müller, Martin ^a   Zentgraf, Hanswalter ^a   Alonso, Angel ^a   Tomakidi, Pascal ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Codon optimization; HPV 11; Major capsid protein L1; Mammalian cells; Virus like particles

Indexed keywords

VIRUS VACCINE;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CODON; DNA MODIFICATION; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS ASSEMBLY; VIRUS EXPRESSION; VIRUS GENE; VIRUS PARTICLE; WART VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CELL LINE; CODON; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED BALB C; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; RNA, VIRAL; TRANSFECTION; VACCINATION; VACCINES, DNA; VIRAL VACCINES; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPES; MAMMALIA; PAPILLOMAVIRUS;

EID: 3242676308     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.04.050     Document Type: Article

References (32)

1. Chen X.S., Casini G., Harrison S.C., Garcea R.L. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J. Mol. Biol. 307(1):2001;173-182
2. Cid-Arregui A., Juarez V., zur Hausen H. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J. Virol. 77(8):2003;4928-4937
3. Collier B., Oberg D., Zhao X., Schwartz S. Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol. 76(6):2002;2739-2752
4. Disbrow G.L., Sunitha I., Baker C.C., Hanover J., Schlegel R. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology. 311(1):2003;105-114
5. Flores E.R., Allen-Hoffmann B.L., Lee D., Sattler C.A., Lambert P.F. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology. 262(2):1999;344-354
6. Gabbott M., Cossart Y.E., Kan A., Konopka M., Chan R., Rose B.R. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J. Clin. Microbiol. 35(12):1997;3098-3103
7. Gelder C.M., Williams O.M., Hart K.W., Wall S., Williams G., Ingrams D., Bull P., Bunce M., Welsh K., Marshall S.E., Borysiewicz L. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J. Virol. 77(3):2003;1927-1939
8. Ghim S.J., Jenson A.B., Schlegel R. HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology. 190(1):1992;548-552
9. Gissmann L., Wolnik L., Ikenberg H., Koldovsky U., Schnurch H.G., zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. U. S. A. 80(2):1983;560-563
10. Gross G. Condylomata acuminata and other HPV-associated manifestations of the genitals and urethra. Guideline of the German STD Society (DSTG). Hautarzt. 52(5):2001;405-410
11. Hagensee M.E., Yaegashi N., Galloway D.A. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67(1):1993;315-322
12. Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. U. S. A. 89(24):1992;12180-12184
13. Koutsky L.A., Galloway D.A., Holmes K.K. Epidemiology of genital human papillomavirus infection. Epidemiol. Rev. 10:1988;122-163
14. Le Cann P., Coursaget P., Iochmann S., Touze A. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol. Lett. 117(3):1994;269-274
15. Leder C., Kleinschmidt J.A., Wiethe C., Muller M. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J. Virol. 75(19):2001;9201-9209
16. Lele S.M., Pou A.M., Ventura K., Gatalica Z., Payne D. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch. Pathol. Lab. Med. 126(10):2002;1184-1188
17. Liu W.J., Qi Y.M., Zhao K.N., Liu Y.H., Liu X.S., Frazer I.H. Association of bovine papillomavirus type 1 with microtubules. Virology. 282(2):2001;237-244
18. Liu W.J., Zhao K.N., Gao F.G., Leggatt G.R., Fernando G.J., Frazer I.H. Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine. 20(5-6):2001;862-869
19. Maw R., von Krogh G. Management of anogenital warts [correction of anal] warts. BMJ. 322(7284):2000;494-495
20. Moore R.A., Edwards J.E., Hopwood J., Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect. Dis. 1(1):2001;3
21. Neeper M.P., Hofmann K.J., Jansen K.U. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae. Gene. 180(1-2):1996;1-6
22. O'Brien P.M., Saveria Campo M. Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res. 88(1-2):2002;103-117
23. Rose R.C., Bonnez W., Reichmann R.C., Garcea R.L. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J. Virol. 67(4):1993;1936-1944
24. Sehr P., Zumbach K., Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J. Immunol. Methods. 253(1-2):2001;153-162
25. Stoler M.H., Whitbeck A., Wolinsky S.M., Broker T.R., Chow L.T., Howett M.K., Kreider J.W. Infectious cycle of human papillomavirus Type 11 in human foreskin xenografts in nude mice. J. Virol. 64(7):1990;3310-3318
26. Tan W., Felber B.K., Zolotukhin A.S., Pavlakis G.N., Schwartz S. Efficient expression of the Human Papillomavirus type 16 L1 protein in epithelial cells by using rev and the rev-responsiveness element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69(9):1995;5607-5620
27. Volpers C., Unckell F., Schirmacher P., Streeck R.E., Sapp M. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 69(6):1995;3258-3264
28. Williams O.M., Hart K.W., Wang E.C., Gelder C.M. Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types. J. Virol. 76(15):2002;7418-7429
29. Wingender E., Chen X., Fricke E., Geffers R., Hehl R., Leibich I., Krull M., Matys V., Michael H., Ohnhauser R., Pruss M., Schacherer F., Thiele S., Urbach S. The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 29:2002;218-283
30. Zhou J., Gissmann L., Zentgraf H., Muller H., Picken M., Muller M. Early phase in the infection of cultured cells with papillomavirus virions. Virology. 214(1):1995;167-176
31. Zhou J., Liu W.J., Peng S.W., Sun X.Y., Frazer I. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol. 73(6):1999;4972-4982
32. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta. 1288(2):1996;55-78